Perrigo receives FDA approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration to market Sulfacetamide Sodium Topical Suspension, 10% (Lotion).
The product has been determined to be therapeutically equivalent (AB) to Sanofi-Aventis’ Klaron(R) (Sodium Sulfacetamide) Lotion, 10%, which is indicated for the topical treatment of acne. Klaron(R) Lotion had sales of [...]



